Is whole-body FDG-PET valuable for health screening? For.
Ide
Michiru
M
HIMEDIC Imaging Center at Lake Yamanaka, Hirano 562-12, Yamanakako-mura, Minamitsuru-gun, Yamanashi, 401-0502, Japan. mide@mfi.or.jp
Suzuki
Yutaka
Y
D019788:Fluorodeoxyglucose F18; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008403:Mass Screening / Q000379:methods* / Q000706:statistics & numerical data; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000453:epidemiology; D049268:Positron-Emission Tomography / Q000379:methods* / Q000706:statistics & numerical data; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D019275:Radiopharmaceuticals; D014915:Whole-Body Counting / Q000379:methods* / Q000706:statistics & numerical data
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
Ann Nucl Med. 2003 Feb;17 (1):1-14
12691125
Ann Nucl Med. 2000 Apr;14 (2):121-6
10830530
Lancet. 1997 Dec 20-27;350(9094):1819
9428255
J Nucl Med. 1999 Aug;40(8):1352-7
10450688
Semin Nucl Med. 2002 Jan;32(1):35-46
11839068
Semin Nucl Med. 2004 Apr;34(2):122-33
15031812
Radiology. 2004 May;231(2):305-32
15044750
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1574-97
14579100
J Nucl Med. 2002 Jul;43(7):871-5
12097455
AJR Am J Roentgenol. 2001 Jun;176(6):1357-62
11373191
Radiographics. 1999 Jan-Feb;19(1):61-77; quiz 150-1
9925392
Eur J Nucl Med. 1998 Jun;25(6):565-74
9618570
J Nucl Med. 1996 Jun;37(6):1038-41
8683297
Ann Oncol. 2001 Nov;12 (11):1605-9
11822762
J Nucl Med. 2003 Aug;44(8):1200-9
12902408
Eur J Nucl Med. 2001 Jun;28(6):696-703
11440029
Br J Cancer. 2000 Dec;83(12 ):1607-11
11104553